L. Ignacio

发表

Results of a phase II concurrent chemoradiotherapy study using three-dimensional conformal radiotherapy with cisplatin and oral etoposide in stage III nonsmall-cell lung cancer.

L. Chen, R. Evans, L. Ignacio, 1999, Radiation oncology investigations.

Acute toxicity in radiotherapy of prostate cancer: Results of a randomized study with and without beam's‐eye view three‐dimensional conformal therapy

George T. Y. Chen, R. Weichselbaum, Srinivasan Vijayakumar, 1996 .

Television and news print media are effective in recruiting potential participants in a prostate cancer chemoprevention trial

Srinivasan Vijayakumar, T. Chung, L. Ignacio, 2000, International Journal of Cancer.

Results of a study to correlate serum prostate specific antigen and reproductive hormone levels in patients with localized prostate cancer.

Srinivasan Vijayakumar, H. Halpern, H. Sutton, 1995, Journal of the National Medical Association.

Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: final report of a randomized, open-labelled, phase II trial.

D. Nicolae, M. Roach, W. Wara, 1998, British Journal of Cancer.

Measurement of weekly prostate specific antigen levels in patients receiving pelvic radiotherapy for nonprostatic malignancies.

R. Weichselbaum, Srinivasan Vijayakumar, S. F. Quadri, 1995, International journal of radiation oncology, biology, physics.

PSA-based outcome analysis after radiation therapy for prostate cancer: a new definition of biochemical failure after intervention.

R. Weichselbaum, Srinivasan Vijayakumar, A. Jani, 1999, Urology.

Equivalent racial outcome after conformal radiotherapy for prostate cancer: a single departmental experience.

R. Weichselbaum, Srinivasan Vijayakumar, H. Halpern, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Caution in interpreting biochemical control rates after treatment of prostate cancer: length of follow-up influences results.

R. Weichselbaum, Srinivasan Vijayakumar, R. McBride, 1999, Urology.

Analysis of weekly complete blood counts in patients receiving standard fractionated partial body radiation therapy.

Srinivasan Vijayakumar, H. Halpern, F. Yang, 1995, International journal of radiation oncology, biology, physics.

Evolution of toxicity after conformal radiotherapy for prostate cancer

R. Weichselbaum, Srinivasan Vijayakumar, A. Jani, 2002, Prostate Cancer and Prostatic Diseases.

Potency probability following conformal megavoltage radiotherapy using conventional doses for localized prostate cancer.

R. Weichselbaum, Srinivasan Vijayakumar, P. Song, 1997, International journal of radiation oncology, biology, physics.

Changing face and different countenances of prostate cancer: Racial and geographic differences in prostate‐specific antigen (PSA), stage, and grade trends in the PSA era

D. Brachman, R. Weichselbaum, J. Moul, 2001, International journal of cancer.

Self-assessed health-related quality of life in men being treated for prostate cancer with radiotherapy: instrument validation and its relation to patient-assessed bother of symptoms.

Srinivasan Vijayakumar, P. Song, W. Dale, 1999, Urology.

Potency preservation following conformal radiotherapy for localized prostate cancer: impact of neoadjuvant androgen blockade, treatment technique, and patient-related factors.

R. Weichselbaum, R. Fields, G. Kandel, 1999, The cancer journal from Scientific American.

Self‐assessed health‐related quality of life in men who have completed radiotherapy for prostate cancer: Instrument validation and its relation to patient‐assessed bother of symptoms

Hong Wang, Srinivasan Vijayakumar, W. Dale, 2000, International journal of cancer.